Senolytic agents like dasatinib and quercetin (D+Q) target age-related cellular senescence and reduce senescent cell activity in various disease processes. In their paper, researchers Erryn Tappy ...
A Mayo Clinic study reveals that senolytic drugs, particularly a combination of dasatinib and quercetin, enhance bone health ...
Aprotex is offering dasatinib tablets, a generic version of Sprycel. The company has 180 days of exclusivity. Dasatinib is a kinase inhibitor used to treat certain types of leukemia in adults and ...
In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback